Lithium Carbonate and Imipramine in Prevention of Affective Episodes: A Comparison in Recurrent Affective Illness
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Patients with recurrent affective illness (N-122) were randomly assigned to lithium carbonate, imipramine, or placebo therapy for two years following discharge from hospitalization for acute depression. Patients were classified as bipolar or unipolar based on the presence or absence of a history of mania. With bipolar patients lithium carbonate was significantly more effective than imipramine or placebo in preventing affective episodes (ie, manic or depressive attacks severe enough to require hospitalization or use of nonstudy drugs). There was a relatively high incidence of manic episodes on imipramine. Unipolar patients responded equally well to lithium carbonate or imipramine. Both treatments were significantly more effective than placebo. The difference between treatments was due primarily to depressive episodes; manic episodes occurred infrequently and were evenly distributed across treatment groups. There was no significant difference between lithium carbonate and imipramine among unipolar patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Tricyclic antidepressant mono or adjunctive maintenance therapy is not recommended due to an increased risk of manic switch (level 2 negative)398, 399, 400”
Citations
Cites
(1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-971_2 · Cited by 705
Baastrup, P. C. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730200030005 · Cited by 570
Baastrup, P. C., Poulsen, J. C., Schou, M., Thomsen, K., & Amdisen, A. (1970) · The Lancet · doi:10.1016/s0140-6736(70)92870-9 · Cited by 505
PROPHYLACTIC LITHIUM IN AFFECTIVE DISORDERS
Coppen, A., Noguera, R., Bailey, J., Burns, B. H., Swani, M. S., Hare, E. H., Gardner, R., & Maggs, R. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91331-6 · Cited by 363
Prien, R. F. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750330035006 · Cited by 287
Self-citationPrien, R. F. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200050011 · Cited by 245
Self-citationLithium Response in Unipolar Versus Bipolar Depression
GOODWIN, F. K., MURPHY, D. L., DUNNER, D. L., & BUNNEY, W. E. (1972) · American Journal of Psychiatry · doi:10.1176/ajp.129.1.44 · Cited by 221
Dohan, F. C. (1966) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1966.tb01912.x · Cited by 164
Prophylactic Lithium: A Double-Blind Trial in Recurrent Affective Disorders
Melia, P. I. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.116.535.621 · Cited by 159
PROPHYLACTIC LITHIUM: ANOTHER THERAPEUTIC MYTH?
Blackwell, B., & Shepherd, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90917-3 · Cited by 158
Cited by
Items 101–200 of 445
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.7.817 · Cited by 76
Amsterdam, J. D., & Shults, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318166c4e6 · Cited by 71
Continuation and maintenance therapy in depression
Paykel, E. S. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.145 · Cited by 73
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.1.31 · Cited by 75
Prediction of Treatment Outcome With Lithium
Carroll, B. J. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080044012 · Cited by 75
Liu, B., Zhang, Y., Fang, H., Liu, J., Liu, T., & Li, L. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.07.023 · Cited by 82
“Prophylaxis of new depressive episodes Five trials (Prien et al., 1984; Prien et al., 1973; Kane et al., 1982; Amsterdam and Shults, 2010; Amsterdam et al., 2015) with 227 patients (122 in AD group and 105 in MS group) compared AD monotherapy with MS monotherapy in prophylaxis of new depressive episodes and inducement…”
BackgroundResultInfluentialMaintenance Therapies in Bipolar Disorder: Focus on Randomized Controlled Trials
Muzina, D. J., & Calabrese, J. R. (2005) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2005.01649.x · Cited by 78
Suicide and Bipolar Disordersa
Jamison, K. R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb27909.x · Cited by 87
Current Therapeutic Profile of Lithium
Gershon, S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130020004 · Cited by 70
Antisuicidal Effects in Mood Disorders: Are They Unique to Lithium?
Tondo, L., & Baldessarini, R. (2018) · Pharmacopsychiatry · doi:10.1055/a-0596-7853 · Cited by 69
“Prien et al. 1973 [46]; MAD, PBO Calabrese et al. 2003 [40]; BD, LTG Lauterbach et al. 2008 [44]; MDD, PBO Licht et al. 2010 [45]; BD, LTG 0.00 0.01 0.10 1.00 10.0 Odds Ratio [95 %CI] [0.10 – 0.50]; p < 0.0001 favors lithium nullPooled OR = 0.22 Tohen et al. 2005 [48]; BD, ONZ Bauer et al. 2000…”
InfluentialLithium Prophylaxis of Bipolar Illness: The Value of Combination Treatment
Peselow, E. D., Fieve, R. R., Difiglia, C., & Sanfilipo, M. P. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.208 · Cited by 70
“In the studies that specifically reported depressive relapses (Baastrup et a!, 1970; Cundall eta!, 1972; Persson, 1972; Prien et al, 1973a,b; Fieve et a!, 1973, 1976), the cumulative depressive relapse rate was 16.6% (3 1/187) on lithium and 33.9% (61/180) on placebo (P<0.00l).”
BackgroundInfluentialThe primacy of mania: A reconsideration of mood disorders
Koukopoulos, A., & Ghaemi, S. N. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.07.006 · Cited by 82
“Fourth, in the only two studies designed to assess the issue [49,134], randomized data exist that antidepressants are associated with rapid cycling and more depression in rapid cyclers, and there are no contrary randomized data from studies designed to examine the topic (as opposed to post-hoc analyses whose positive…”
BackgroundAntidepressants and suicidal behavior in bipolar disorder
McElroy, S. L., Kotwal, R., Kaneria, R., & Keck, P. E. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00348.x · Cited by 71
“In the imipramine trial described above, the risk for manic conversion increased over time and was not limited to the period right after antidepressant initiation (134).”
BackgroundVenlafaxine Versus Placebo in the Preventive Treatment of Recurrent Major Depression
Montgomery, S. A., Entsuah, R., Hackett, D., Kunz, N. R., Rudolph, R. L., & Venlafaxine 335 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0307 · Cited by 69
Long-Term Treatment of Depression
Montgomery, S. A. (1994) · British Journal of Psychiatry · doi:10.1192/s0007125000293264 · Cited by 69
Hollon, S. D., Evans, M. D., & DeRubeis, R. J. (1990) · Springer eBooks · doi:10.1007/978-1-4613-0649-8_8 · Cited by 78
Bipolar Depression: Management Options
Malhi, G. S., Mitchell, P. B., & Salim, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00002 · Cited by 69
Maintenance therapy with amitriptyline: a controlled trial
Stein, M. K., Rickels, K., & Weise, C. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.3.370 · Cited by 65
Calabrese, J. R., Goldberg, J. F., Ketter, T. A., Suppes, T. M., Frye, M. A., White, R., DeVeaugh‐Geiss, A., & Thompson, T. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.034 · Cited by 64
Electroconvulsive Therapy in the Treatment-Resistant Patient
Devanand, D. P., Sackeïm, H. A., & Prudic, J. (1991) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(18)30275-2 · Cited by 64
Wilkinson, S. T., Diaz, D. T., Rupp, Z. W., Kidambi, A., Ramírez, K. L., Flores, J. M., Avila-Quintero, V. J., Rhee, T. G., Olfson, M., & Bloch, M. H. (2021) · Depression and Anxiety · doi:10.1002/da.23222 · Cited by 66
Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice
Coryell, W. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00712.x · Cited by 64
“Stallone et al. 1973 (39) BPI, manic or depressed 2 Lithium = 25 3 (12.0) 4 (16.0) 18 (72.0) Placebo = 27 18 (66.7) 2 (7.4) 7 (25.9) Prien et al. 1973 (40) BPI, depressed 2 Lithium = 18 1 (5.6) 4 (22.2) 13 (72.2) Placebo = 13 6 (46.2) 3 (23.1) 4 (30.8) Prien et al. 1973 (41); Prien et al. 1974…”
InfluentialMaj, M. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020202.x · Cited by 73
Bipolar Affective Disorder: Causes and Prevention of Relapse
Silverstone, T., & Romans-Clarkson, S. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.3.321 · Cited by 61
Beynon, S., Soares-Weiser, K., Woolacott, N., Duffy, S., & Geddes, Jr. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093885 · Cited by 61
The androgen model of suicide completion
Lenz, B., Röther, M., Bouna-Pyrrou, P., Mühle, C., Tektas, O. Y., & Kornhuber, J. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.003 · Cited by 62
Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression
Bottlender, R., Rudolf, D., Strauß, A., & Möller, H. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050053 · Cited by 68
The Switch Process in Manic-Depressive Psychosis
Bunney, W. E., WEHR, T. R., GILLIN, J. C., POST, R. M., GOODWIN, F. K., & van KAMMEN, D. P. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-319 · Cited by 60
Antidepressant monotherapy for bipolar type II major depression
Amsterdam, J. D., & Brunswick, D. J. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00066.x · Cited by 58
“(22) reported the presence of drug-induced mania in 67% of 44 BP I depressed patients taking imipramine, 12% of patients taking lithium, and 33% of patients taking placebo.”
BackgroundA case of mania associated with fluoxetine
Settle, E. C., & Settle, G. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.2.280 · Cited by 58
Koch‐Weser, J., & Hollister, L. E. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811232992105 · Cited by 58
Critical issues in the treatment of affective disorders
Brunello, N., Burrows, G. D., Jonsson, B., Judd, L. L., Kasper, S., Keller, M. B., Kupfer, D. J., Lecrubier, Y., Mendlewicz, J., Montgomery, S. A., et al. (1995) · Depression · doi:10.1002/depr.3050030406 · Cited by 56
Early Termination of Antidepressant Drug Treatment
Linden, M., Gothe, H., Dittmann, R. W., & Schaaf, B. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200010000-00005 · Cited by 56
Yatham, L. N., Calabrese, J. R., & Kusumakar, V. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00019.x · Cited by 59
Long-term treatment of depression
Lecrubier, Y. (1993) · European Psychiatry · doi:10.1017/s0924933800004144 · Cited by 54
Stefos, G., Bauwens, F., Staner, L., Pardoen, D., & Mendlewicz, J. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10672.x · Cited by 60
Berghöfer, A., Kossmann, B., & Müller‐Oerlinghausen, B. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb10659.x · Cited by 54
“They were selected according to the following criteria: (1) lithium treatment in the lithium clinic for at least 3 years; (2) confirmed diagnosis; and (3) complete documentation.”
MethodAn update of evidence-based treatment of bipolar depression: where do we stand?
Fountoulakis, K. Ν. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328333e132 · Cited by 57
Kasper, S. F., Volz, H., Möller, H. ‐., Dienel, A., & Kieser, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.006 · Cited by 61
A Long-term Retrospective Follow-up Study of Patients Treated with Prophylactic Lithium Carbonate
Page, C., Benaim, S., & Lappin, F. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.150.2.175 · Cited by 54
Receptor targets for antidepressant therapy in bipolar disorder: An overview
Fountoulakis, K. Ν., Kelsoe, J. R., & Akiskal, H. S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.04.043 · Cited by 54
The Lithium Ion: A Foundation for Psychopharmacological Specificity
Soares, J., & Gershon, S. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00022-0 · Cited by 56
“In the prophylaxis of unipolar depression, lithium was better than placebo in most studies (Prien et al. 1973b; Fieve et al. 1975,1976; Kane et al. 1982; Glen et al. 1984).”
BackgroundProphylaxis of Affective Disorders: Current Status of Knowledge
Quitkin, F. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030051007 · Cited by 52
Fieve, R. R., Dunner, D. L., Kumbarachi, T., & Stallone, F. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760300079006 · Cited by 52
The Practical Management of Affective Disorders
Shaw, D. M. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.130.5.432 · Cited by 52
Nierenberg, A. A., Quitkin, F. M., Kremer, C., Keller, M. B., & Thase, M. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300405 · Cited by 51
“…problem since recurrence rates vary from 15 to 40% in long-term clinical trials, a proportion mirrored in clinical practice (Coppen et al, 1978; Prien et al, 1973, 1984; Montgomery et al, 1988; Rouillon et al, 1989; Frank et al, 1990; Doogan and Caillard, 1992; Kupfer et al, 1992; Montgomery…”
BackgroundBaghai, T. C., Blier, P., Baldwin, D. S., Bauer, M., Goodwin, G. M., Fountoulakis, K. Ν., Kasper, S. F., Leonard, B. E., Malt, U. F., Stein, D. J., et al. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0259-6 · Cited by 54
Treatment of unipolar depression following electroconvulsive therapy
Perry, P. J., & Tsuang, M. T. (1979) · Journal of Affective Disorders · doi:10.1016/0165-0327(79)90031-4 · Cited by 50
Kishi, T., Matsuda, Y., Sakuma, K., Okuya, M., Mishima, K., & Iwata, N. (2021) · Psychological Medicine · doi:10.1017/s0033291720003505 · Cited by 48
Treatment of Bipolar Depression, a Review of the Literature and a Suggestion for an Algorithm
Nolen, W. A., & Bloemkolk, D. (2000) · Neuropsychobiology · doi:10.1159/000054845 · Cited by 49
Hah, M., & Chang, K. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.996 · Cited by 48
“Thus, although not a stimulant, the potential antidepressant properties of atomoxetine raise the possibility that it may induce mania in patients with BD, similar to other antidepressants (Altshuler et al. 1995; Prien et al. 1973).”
Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study
Biel, M. G., Peselow, E., Mulcare, L., Case, B. G., & Fieve, R. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00389.x · Cited by 47
The International Register of Lithium Babies
Weinstein, M. R. (1976) · Drug Information Journal · doi:10.1177/009286157601000210 · Cited by 48
Increased number of peripheral blood CD34 + cells in lithium‐treated patients
Ballin, A., Lehman, D., Sirota, P., Litvinjuk, U., & Meytes, D. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00537.x · Cited by 48
“…serum lithium concentrations in British Journal of Haematology, 1998, 100, 219–221 219q 1998 Blackwell Science Ltd Correspondence: Dr A. Ballin, Paediatric Haematology Unit, E. Wolfson Medical Centre, Holon 58100, Israel. order to achieve the therapeutic range of 0·8–1·2 mmol/l (Prien et al, 1972).”
BackgroundA review of acute treatments for bipolar depression
Silverstone, P. H., & Silverstone, T. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200405000-00001 · Cited by 54
Mania Associated with Fluoxetine Treatment in Adolescents
Venkataraman, S., Naylor, M. W., & King, C. A. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00015 · Cited by 48
Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review
Visser, H. M., & Van Der Mast, R. C. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029885 · Cited by 47
“For example, Prien et al. (1973, 1984) studied the preventive effect of different treatment regimens in the continuation and maintenance phase on the emergence of mood episodes, and Cohn et al. (1989), Nemeroff et al. (2001) and Himmelhoch et al. (1991) studied the antidepressant effect of…”
BackgroundResultInfluentialHirschfeld, R. M. A. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2000.tb10946.x · Cited by 45
Current Antidepressant Drugs: Their Clinical Use
Hollister, L. E. (1981) · Drugs · doi:10.2165/00003495-198122020-00003 · Cited by 46
Refractoriness in Bipolar Disorder: Definitions and Evidence‐Based Treatment
Fountoulakis, K. N. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00259.x · Cited by 44
Case report of a toxic reaction from a combination of tryptophan and phenelzine
Thomas, J. M., & Rubin, E. H. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.2.281 · Cited by 45
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.5.570 · Cited by 45
Relationship between dosage and response to lithium prophylaxis in recurrent depression
Prien, R. F., & Caffey, E. M. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.5.567 · Cited by 45
Self-citationReassessing the bipolar-unipolar dichotomy
Taylor, M. A., & Abrams, R. (1980) · Journal of Affective Disorders · doi:10.1016/0165-0327(80)90005-1 · Cited by 44
Maintenance therapies for classic and other forms of bipolar disorder
Bowden, C. L., Lecrubier, Y., Bauer, M. S., Goodwin, G. M., Greil, W., Sachs, G. S., & von Knorring, L. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00179-8 · Cited by 45
Achieving gains beyond response
Paykel, E. S. (2002) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.106.s415.3.x · Cited by 40
Lithium Monotherapy: Miracle, Myth and Misunderstanding
Sachs, G. S., Lafer, B., Truman, C. J., Noeth, M., & Thibault, A. B. (1994) · Psychiatric Annals · doi:10.3928/0048-5713-19940601-09 · Cited by 40
Drug-Induced Switching in Bipolar Disorder: Epidemiology and Therapeutic Implications
Post, R. M., Denicoff, K. D., Leverich, G. S., & Frye, M. A. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00002 · Cited by 41
Lamotrigine in the treatment of bipolar disorder
Bowden, C. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.10.1513 · Cited by 39
“However, because most studies have principally been aimed at assessing efficacy for the depressive aspects of lamotrigine, the studies have also had design constraints, since few antidepressants have ever been tested in placebocontrolled trials limited to bipolar disorder [1-6].”
BackgroundLithium in the Prophylactic Treatment of Affective Disorders
Prien, R. J. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780080021005 · Cited by 39
Self-citationLamotrigine-associated rash: to rechallenge or not to rechallenge?
Lorberg, B. A., Youssef, N. A., & Bhagwagar, Z. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009504 · Cited by 39
Placebo effect in randomized, controlled maintenance studies of patients with bipolar disorder
Keck, P. E., Welge, J. A., Strakowski, S. M., Arnold, L. M., & McElroy, S. L. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00309-1 · Cited by 63
Björk, K. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb11122.x · Cited by 38
Lithium therapy: from clinical trials to practical management
Coppen, A. J., & Abou-Saleh, M. T. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06415.x · Cited by 37
Avoiding Drug-Induced Switching in Patients with Bipolar Depression
Henry, C., & Demotes‐Mainard, J. (2003) · Drug Safety · doi:10.2165/00002018-200326050-00003 · Cited by 39
Loss of drug effects during continuation therapy
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.562 · Cited by 36
Is Your ‘Double-Blind’ Design Truly Double-Blind?
Oxtoby, A., Jones, A., & Robinson, M. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.155.5.700 · Cited by 35
Dr. Christodoulou and Associates Reply
Christodoulou, G. N., Malliaras, D., Lykouras, E., Papadimitriou, G. N., & STEFANIS, C. N. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.8.1001-a · Cited by 35
Revised Korean medication algorithm for bipolar disorder
Jon, D., Bahk, W., Yoon, B. H., Shin, Y. C., Cho, H. S., Lee, E. M., Ha, K., Kim, W. K., Chung, S. K., Seo, J. S., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802144865 · Cited by 35
“This change might be due to clinical studies (Prien et al. 1973; Cohn et al. 1989; Peet 1994; Ghaemi et al. 2003) and the personal experiences of manic switches, and also by the many lectures for psychiatrists on bipolar disorder in Korea.”
BackgroundInternational Consensus Group on Depression Prevention in Bipolar Disorder
Frye, M. A., Ha, K., Kanba, S., Kato, T., McElroy, S. L., Özerdem, A., Vázquez, G., & Vieta, E. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10123co1c · Cited by 31
Strategies for preventing the recurrence of bipolar disorder.
Ghaemi, S. N., Pardo, T. B., & Hsu, D. J. (2004) · PubMed · Cited by 34
Weiss, B. L., Foster, F. G., Reynolds, C. F., & Kupfer, D. J. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760150083012 · Cited by 34
Henry, J. A., & Rivas, C. A. (1997) · PharmacoEconomics · doi:10.2165/00019053-199711050-00005 · Cited by 36
(1981) · Psychological Medicine · doi:10.1017/s0033291700052235 · Cited by 34
Sultzer, D. L., & Cummings, J. L. (1989) · Drug Safety · doi:10.1007/bf03259908 · Cited by 33
Depression: New Evidence in Support of Biological Differentiation
Garfinkel, P. E., Warsh, J. J., & Stancer, H. C. (1979) · American Journal of Psychiatry · doi:10.1176/ajp.1979.136.4b.535 · Cited by 33
The lithium clinic: a new model for the delivery of psychiatric services
Rr, F. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.10.1018 · Cited by 32
Two case reports of trazodone-induced mania
Warren, M., & Bick, P. A. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.9.1103 · Cited by 31
Discontinuation reactions to alprazolam in panic disorder
Pecknold, J. C. (1993) · Journal of Psychiatric Research · doi:10.1016/0022-3956(93)90025-w · Cited by 36
Continuation therapy in endogenous depression controlled by changes in the TRH stimulation test
KIRKEGAARD, C., & Smith, E. (1978) · Psychological Medicine · doi:10.1017/s0033291700016202 · Cited by 31
“This figure is in agreement with previous studies (17-37%, mean 25%) (Seager & Bird, 1962; JfLayetal. 1970; Mindhamef al. 1972; Prien et al. 1973).”
ResultPharmacologic Treatment of Child and Adolescent Depression
Kye, C., & Ryan, N. D. (1995) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/s1056-4993(18)30433-4 · Cited by 33
Petrides, G. (1998) · Psychiatric Annals · doi:10.3928/0048-5713-19980901-09 · Cited by 30
Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses
Stensland, M. D., Schultz, J. F., & Frytak, J. R. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-39 · Cited by 27
“Well-controlled clinical trials have found that antidepressant monotherapy, particularly with tricyclic antidepressants, in patients with bipolar disorder can induce mania at a higher rate than placebo [23].”
BackgroundSwitch from depression to mania, or from mania to depression
Angst, J. (1987) · Journal of Psychopharmacology · doi:10.1177/026988118700100104 · Cited by 30
Bowie, P. C. W., & Beaini, A. Y. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.1.30 · Cited by 32
Marini, J. L., & Sheard, M. H. (1976) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1976.tb02405.x · Cited by 30
Four year follow-up of first episode manic patients.
Khess, C. R. J., Das, J., & Akhtar, S. (1997) · PubMed Central · Cited by 29
Large simple trials in psychiatry: providing reliable answers to important clinical questions
Geddes, J. R. (2005) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00006357 · Cited by 29
“…notably long-term treatment with antipsychotics (Leff & Wing, 1971), continuation treatment with antidepressants (Mindham et al., 1972), treatment of acute mania with lithium and chlorpromazine and prevention of relapse with lithium in both bipolar and unipolar disorders (Prien et al., 1973a, b).”
BackgroundIs the placebo effect dependent on time? A meta-analysis.
Walach, H., & Maidhof, C. (2004) · American Psychological Association eBooks · doi:10.1037/10332-013 · Cited by 29
Testing for Antisuicidal Effects of Lithium Treatment
Baldessarini, R. J., & Tondo, L. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.2992 · Cited by 28
Metadata
- Authors
- Prien, R. F.
- Corresponding author
- Prien, Robert F.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1973-09-01
- Volume
- 29
- Issue
- 3
- Pages
- 420
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2058662910
- Cited by
- 448
- References
- 19
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 9 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 7 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 18.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lithium carbonate, imipramine, bipolar disorder, major depressive disorder, manic episodes, depressive episodes, maintenance therapy, tricyclic antidepressants
- MeSH terms
- Adult, Affective Symptoms, Age Factors, Clinical Trials as Topic, Depression, Female, Hospitalization, Humans, Imipramine, Lithium, Male, Middle Aged, Placebos, Recurrence, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.